Clinical Trials Browser

Phase 1 × neratinib × 30 days × Clear all

NCT05372614 2026-03-19

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Phase 1 Suspended

Neoplasm Metastasis